Page last updated: 2024-12-06

fubrogonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

fubrogonium: RN given refers to iodide; structure in Negwer, 5th ed, #2650 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71530
CHEMBL ID2110930
MeSH IDM0051188

Synonyms (19)

Synonym
fubrogonium
3-(5-bromofuran-2-carbonyl)oxybutyl-diethyl-methylazanium
fubrogonium ion
unii-w75l464pea
w75l464pea ,
1-butanaminium, 3-(((5-bromo-2-furanyl)carbonyl)oxy)-n,n-diethyl-n-methyl
26660-74-2
fubrogonium cation
diethyl (3-hydroxybutyl)methylammonium 5-bromo-2-furoate
3-{[(5-bromofuran-2-yl)carbonyl]oxy}-n,n-diethyl-n-methylbutan-1-aminium
STL371211
MLS006011724
smr004703443
AKOS025247583
CHEMBL2110930
sr-01000945192
SR-01000945192-1
SR-01000945192-2
Q27292428
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]